Dabur India Limited, Dabur Corporate Office, Kaushambi Sahibabad Ghaziabad 201010 IndiaFEI 3001413302Issued Jul 24, 2026Center for Drug Evaluation and Research (CDER)
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3001413302.
Violations4
Issue DateJul 24, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Dabur India Limited
Location
Dabur India Limited, Dabur Corporate Office, Kaushambi Sahibabad Ghaziabad 201010 India
FEI Number
3001413302
Country
India
Issue Date
July 24, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/Finished Pharmaceuticals/Adulterated
Dabur India Limited FDA Warning Letter, July 24, 2026
Talk to a Specialist